Sign in

NCT06206629Completed

Contralateral R1 in Amyotrophic Lateral Sclerosis

Evaluation of Contralateral R1 Component of the Blink Reflex in Patients With Amyotrophic Lateral Sclerosis

Source: ClinicalTrials.gov · Last updated 9 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting both upper and lower motor neurons. Electroneuromyography is an important tool for the diagnosis. Previous studies have shown that different components of the blink reflex, such as the latencies of homo- and contralateral R2 responses can be affected. Studies have found that a contralateral R1 component can appear in neurological diseases with affection of the central nervous system especially upper motor neuron, such as HTLV1 infection. Thus, you aim to determine if a contralateral R1 component could be present in ALS.

Status (registry)
Completed
Study type
Observational
Enrollment
120 (actual)
First submitted
4 Jan 2024
Start date
15 Feb 2024
Primary completion date
5 Sept 2024
Lead sponsor
Hospices Civils de Lyon
NCT number
NCT06206629

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From 15 Feb 2024 to the primary completion date, 5 Sept 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous damage linked to another cause of the cranial nerves
  • Prior brainstem lesions

Other

  • Persons deprived of liberty by a judicial or administrative decision
  • Patient under judicial protection, unable to express consent

Who the study is looking for

  • For patients
  • Aged 18 to 99 years old
  • Referred for suspected motor neuromuscular disease
  • Collection of non-opposition
    • For healthy subjects:
  • Aged 18 to 99 years old
  • Absence of any neurological pathology
  • Collection of non-opposition

Age in the registry: 18 years to 99 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Neurologique Pierre Wertheimer
Coordinator of this site? Confirm its status
BronFranceUnknown status
CHU de Nantes
Coordinator of this site? Confirm its status
NantesFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.